Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1643197 | 1.00 | GNRHR (1.00) | GNRHRCYP3A4 | |
| SCHEMBL1643199 | 1.00 | GNRHR (1.00) | GNRHRCYP3A4 | |
| SCHEMBL1643200 | 1.00 | GNRHR (1.00) | GNRHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL29816173 | 0.99 | GNRHR (0.98) | GNRHRCYP3A4 | |
| Oxalic Acid SCHEMBL29816324 | 0.97 | GNRHR (0.94) | GNRHRCYP3A4 | |
| SCHEMBL5758028 | 0.92 | GNRHR (1.00) | GNRHRCYP3A4 | |
| SCHEMBL5758037 | 0.92 | GNRHR (1.00) | GNRHRCYP3A4 | |
| SCHEMBL30299007 | 0.92 | GNRHR (1.00) | GNRHRCYP3A4 | |
| SCHEMBL5758034 | 0.92 | GNRHR (1.00) | GNRHRCYP3A4 | |
| Salicylic Acid SCHEMBL28522582 | 0.92 | GNRHR (0.85) | GNRHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118772067-A | Method for purifying oxaagole sodium intermediate | 金陵药业股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-114790178-B | Preparation method of oxaagoli sodium | 福安药业集团宁波天衡制药有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-114814038-B | HPLC detection method for sodium Igacross bulk drug and related substances thereof | 常州制药厂有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-114814038-A | HPLC detection method for ilagox sodium raw material medicine and related substances thereof | 常州制药厂有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114790178-A | Preparation method of oxa-goril sodium | 福安药业集团宁波天衡制药有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-118772067-A | Method for purifying oxaagole sodium intermediate | 金陵药业股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118772067-A | Method for purifying oxaagole sodium intermediate | 金陵药业股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-114790178-B | Preparation method of oxaagoli sodium | 福安药业集团宁波天衡制药有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117545484-A | Oxaagoli sodium composition | 上海启晟合研医药科技有限公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11858901-B2 | 3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6 trifluoromethyl benzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione or a salt thereof, process for its preparation, and its use in the synthesis of elagolix | MOEHS IBERICA, S.L. (ES) | 2024-01-02 | — | — | US | disclosed |
| CN-111072572-B | Crystal forms of hydrogen sulfate of Elagolix key intermediate, preparation and application thereof | 安礼特（上海）医药科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-114814038-B | HPLC detection method for sodium Igacross bulk drug and related substances thereof | 常州制药厂有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-116026966-A | Detection method for determining related substances of oxaagole sodium by HPLC | 哈药集团技术中心 | 2023-04-28 | — | — | CN | disclosed |
| CN-110498770-B | Method for preparing intermediate of oxaagolide | 上海医药工业研究院 | 2023-02-17 | — | — | CN | disclosed |
| CN-110498771-B | Method for preparing intermediate of pergolide | 上海医药工业研究院 | 2023-02-17 | — | — | CN | disclosed |
| US-20220411382-A1 | 3-((R)-2-(AMINO-2-PHENYLETHYL)-1-(2-FLUORO-6 TRIFLUOROMETHYL BENZYL)-5-IODO-6-METHYL-1H-PYRIMIDINE-2,4-DIONE OR A SALT THEREOF, PROCESS FOR ITS PREPARATION, AND ITS USE IN THE SYNTHESIS OF ELAGOLIX | MOEHS IBERICA S.L. (ES) | 2022-12-29 | — | — | US | disclosed |
| CN-115466224-A | Salt forming method and purification method of oxalagogri intermediate I | 成都倍特药业股份有限公司 | 2022-12-13 | — | — | CN | disclosed |
| WO-2022222886-A1 | ELAGOLIX SODIUM COMPOSITION | 上海启晟合研医药科技有限公司 | 2022-10-27 | — | — | WO | disclosed |
| CN-114814038-A | HPLC detection method for ilagox sodium raw material medicine and related substances thereof | 常州制药厂有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114790178-A | Preparation method of oxa-goril sodium | 福安药业集团宁波天衡制药有限公司 | 2022-07-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411382-A1 | 3-((R)-2-(AMINO-2-PHENYLETHYL)-1-(2-FLUORO-6 TRIFLUOROMETHYL BENZYL)-5-IODO-6-METHYL-1H-PYRIMIDINE-2,4-DIONE OR A SALT THEREOF, PROCESS FOR ITS PREPARATION, AND ITS USE IN THE SYNTHESIS OF ELAGOLIX | JAK2, EML4, AZI2 | GNRHR 4166/4885CYP3A4 3862/4885 |
| US-11858901-B2 | 3-((R)-2-(amino-2-phenylethyl)-1-(2-fluoro-6 trifluoromethyl benzyl)-5-iodo-6-methyl-1H-pyrimidine-2,4-dione or a salt thereof, process for its preparation, and its use in the synthesis of elagolix | JAK2, EML4, AZI2 | GNRHR 4166/4885CYP3A4 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.